Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cassava To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cassava between February 7, 2024 and November 24, 2024 and would like to…
Month: January 2025
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kyverna To Contact Him Directly To Discuss Their Options If you purchased or acquired securities investing Kyverna common stock pursuant and/or traceable to the Offering…
New Zealand targets cutting emissions by 51% to 55% by 2035
The Climate Fix: Africa’s Solar Revolution
IFRS Publishes Guidance for Companies Taking a Climate-First Approach to Sustainability Reporting
4 Questions Leaders Must Ask To Navigate Sustainability In 2025
2025 the Turning Point for Nature-Positive Finance, says WEF
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Customers Bancorp
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Customers Bancorp To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Customers Bancorp between March 1, 2024 and August 8, 2024 and…
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management SILVER SPRING, Md., Jan. 30, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral…
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marqeta
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Marqeta To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Marqeta between May 7, 2024 and November 4, 2024 and would like to discuss…
